Cwm LLC Increases Stake in Chemed Corporation $CHE

Key Points

• Cwm LLC significantly increased its stake in Chemed Corporation by 347.5% during the second quarter, resulting in holdings worth $917,000.
• Chemed Corporation recently announced a quarterly dividend increase to $0.60 per share, up from the previous $0.50, reflecting a 0.5% dividend yield.
• Wall Street analysts maintain a consensus rating of "Moderate Buy" for Chemed shares, with an average price target of $578.50.

Cwm LLC increased its holdings in shares of Chemed Corporation (NYSE:CHE - Free Report) by 347.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,884 shares of the company's stock after buying an additional 1,463 shares during the period. Cwm LLC's holdings in Chemed were worth $917,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the business. Renasant Bank increased its stake in Chemed by 2.3% during the 1st quarter. Renasant Bank now owns 815 shares of the company's stock worth $501,000 after buying an additional 18 shares during the period. Cim LLC increased its position in shares of Chemed by 1.0% in the 1st quarter. Cim LLC now owns 2,029 shares of the company's stock valued at $1,248,000 after purchasing an additional 21 shares during the last quarter. First Horizon Advisors Inc. increased its position in shares of Chemed by 16.1% in the 1st quarter. First Horizon Advisors Inc. now owns 173 shares of the company's stock valued at $107,000 after purchasing an additional 24 shares during the last quarter. Cynosure Group LLC increased its position in shares of Chemed by 4.3% in the 1st quarter. Cynosure Group LLC now owns 581 shares of the company's stock valued at $358,000 after purchasing an additional 24 shares during the last quarter. Finally, Brogan Financial Inc. increased its position in shares of Chemed by 7.3% in the 1st quarter. Brogan Financial Inc. now owns 426 shares of the company's stock valued at $262,000 after purchasing an additional 29 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Price Performance

Shares of NYSE:CHE opened at $441.75 on Wednesday. Chemed Corporation has a 1-year low of $408.42 and a 1-year high of $623.60. The stock has a market cap of $6.44 billion, a P/E ratio of 22.71, a P/E/G ratio of 2.59 and a beta of 0.43. The firm has a fifty day moving average price of $449.11 and a 200 day moving average price of $501.36.

Chemed (NYSE:CHE - Get Free Report) last released its earnings results on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing the consensus estimate of $6.02 by ($1.75). Chemed had a return on equity of 25.83% and a net margin of 11.56%.The firm had revenue of $618.80 million during the quarter, compared to analyst estimates of $650.60 million. During the same quarter last year, the business posted $5.47 EPS. The firm's revenue was up 3.8% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Sell-side analysts expect that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were paid a $0.60 dividend. This is a boost from Chemed's previous quarterly dividend of $0.50. The ex-dividend date was Monday, August 11th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. Chemed's dividend payout ratio (DPR) is 12.34%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on CHE shares. Royal Bank Of Canada dropped their price objective on shares of Chemed from $640.00 to $589.00 and set an "outperform" rating on the stock in a research report on Thursday, July 31st. Jefferies Financial Group raised shares of Chemed from a "hold" rating to a "buy" rating and increased their price objective for the company from $490.00 to $550.00 in a research report on Tuesday, September 2nd. Weiss Ratings reissued a "hold (c-)" rating on shares of Chemed in a research report on Wednesday, October 8th. Bank of America lowered their target price on shares of Chemed from $610.00 to $595.00 and set a "buy" rating for the company in a report on Wednesday, September 10th. Finally, Oppenheimer lowered their target price on shares of Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, Chemed presently has a consensus rating of "Moderate Buy" and an average price target of $578.50.

Insider Activity

In other news, Director George J. Walsh III bought 200 shares of Chemed stock in a transaction dated Monday, August 4th. The stock was bought at an average price of $417.10 per share, for a total transaction of $83,420.00. Following the purchase, the director owned 3,523 shares of the company's stock, valued at approximately $1,469,443.30. The trade was a 6.02% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 3,000 shares of the firm's stock in a transaction on Friday, September 26th. The stock was sold at an average price of $461.28, for a total transaction of $1,383,840.00. Following the completion of the sale, the chief executive officer owned 96,197 shares of the company's stock, valued at $44,373,752.16. This trade represents a 3.02% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,162 shares of company stock worth $5,677,511 over the last quarter. Insiders own 3.29% of the company's stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.